Though the cancer cell-intrinsic roles of NR4A1 have been extensively characterized in previous studies (Li et al., 2000, 2018; Smith et al., 2011), our current study strongly supports that NR4A1 degradation leads to immune activation within the TME. Here, NR4A1 is linked to cancer.